HSC Exam Practice

Sample response. Long-term population change is a lasting shift in genetic patterns or biological outcomes across many generations — operationally, a change in allele frequencies in a population's gene pool that persists over time.

Marking notes. 1 mark for identifying it as a lasting / multi-generational shift; 1 mark for linking it to genetic patterns / allele frequency / gene pool. Both required for full marks.

Sample response. Scientific capability is whether a biotechnology actually works at the laboratory or trial level — its biological effectiveness. Uptake is the extent to which that technology is actually adopted, repeated and used in real populations. Capability is necessary but not sufficient for long-term population change; without uptake, the capability does not translate into population-level effect.

Marking notes. 1 mark for defining scientific capability; 1 mark for defining uptake; 1 mark for stating that capability is necessary but not sufficient (or equivalent — capability alone does not change populations).

Sample response. Acceptable factor + classification pairings include: cost / patents — economic; public trust / risk perception — social; religious or traditional values — cultural; gene-technology bans or permits — regulatory; Indigenous land-council decisions — cultural (or social, with justification).

Marking notes. 1 mark per correctly named factor paired with the correct classification (max 2). A correct factor without the classification, or vice versa, scores 0 for that entry.

Sample response. Policy is shaped by more than the scientific risk assessment. Two countries may share the same biological data but apply different social values, cultural traditions and economic structures to that data. For example, public trust in regulators, cultural attitudes toward genetic modification, lobbying by commercial interests and different regulatory frameworks can all lead to different decisions — GM crops are approved in some countries and banned in others on near-identical scientific evidence.

Marking notes. 1 mark for identifying that policy depends on more than the scientific risk assessment; 1 mark for naming at least two non-scientific factors (social / cultural / economic / regulatory); 1 mark for a worked example such as GM-crop divergence between jurisdictions.

Sample response. Indigenous and community perspectives are part of biotechnology decision-making because technologies can affect land, species management, food systems, identity and local control. These groups may evaluate risk, benefit, fairness and ownership differently from commercial or laboratory stakeholders, and their acceptance or rejection directly shapes whether a biotechnology is adopted at all. Their role is part of practical scientific decision-making, not an external obstacle.

Marking notes. 1 mark for identifying that these perspectives are legitimate parts of decision-making (not external obstacles); 1 mark for naming at least one specific reason they matter (land, species management, food systems, identity, ownership, fairness); 1 mark for explicitly linking these perspectives to whether a technology is actually adopted (i.e. to uptake).

Sample response (a). In Region P, allele R rises steeply from about 0.05 at generation 0 to roughly 0.78 by generation 30 — a near-sweep. In Region Q, R rises more slowly, from about 0.05 to roughly 0.32 by generation 30. In Region R, the frequency remains essentially flat at around 0.05–0.06 across all generations.

Sample response (b). All three regions have identical scientific capability (the allele itself is the same), so the difference in trajectory cannot be biological. Region P has full uptake — the biotechnology is widely and repeatedly adopted, so the allele is introduced into nearly every breeding population and selection raises its frequency over generations. Region R has scientific capability intact but the technology is prohibited (regulation), so uptake is zero and allele frequency does not change. The contrast between P and R shows that long-term population change requires both capability and uptake.

Marking notes. Part (a) — 1 mark for describing P; 1 mark for describing Q; 1 mark for describing R; quoted values are required for full marks. Part (b) — 1 mark for stating that capability is identical in all three regions; 1 mark for explaining Region P in terms of widespread uptake; 1 mark for explaining Region R in terms of regulation blocking uptake despite intact capability.

Sample response. Figure 2.1 directly supports the statement. The fact that the curves diverge despite identical scientific capability shows that long-term population change is not biologically determined — capability alone produces nothing in Region R. At the same time, the rise in Region P shows that change is biologically possible: where social, economic and regulatory contexts permit uptake, allele frequencies do shift over generations. The position of Region Q — partial uptake, partial change — confirms that the size of the long-term change is proportional to the extent of social uptake. Long-term population change is therefore biologically possible but socially mediated.

Marking notes. 1 mark for using the divergence between P and R to argue against biological determinism; 1 mark for using Region P to argue that change is biologically possible when uptake is permitted; 1 mark for using Region Q to argue that the magnitude of change scales with uptake; 1 mark for an explicit closing judgement that restates "biologically possible but socially mediated" with reference to the figure.

Sample response. The claim that artificial DNA manipulation will inevitably change populations forever overstates the case. The scientific capability to manipulate DNA is real — recombinant DNA, CRISPR-Cas9 and reproductive technologies can directly alter which genetic traits enter future generations, so artificial manipulation has the potential to produce long-term population change. However, capability alone is not sufficient; long-term population change requires repeated, broad and lasting uptake, which depends on social, economic, cultural and regulatory context. Bt cotton in India illustrates the positive case: high capability combined with high economic and regulatory access produced uptake above 90% of acreage and a near-fixation of the cry1Ac transgene in commercial cotton populations within two decades — a real, multi-species long-term population change. By contrast, germ-line CRISPR (e.g. the He Jiankui CCR5 edits) has comparable scientific capability but is criminalised in most jurisdictions, broadly rejected by the public, and challenged by community and Indigenous decision-making bodies that see human-genome modification as touching identity, lineage and country. As a result, despite the existence of the technology, allele-frequency change at the human population level has been essentially zero. Indigenous and community perspectives are not obstacles in this picture — they are legitimate parts of how biotechnology decisions are actually made, especially where ownership, fairness and lasting consequences are at stake. The claim is therefore rejected as too absolute. Artificial manipulation of DNA can change populations over long time scales, but only when scientific capability is matched by social, economic, cultural and regulatory uptake. The future is biologically possible but socially mediated.

Marking notes. 1 mark — concedes the defensible element (capability exists; artificial DNA manipulation can potentially change populations). 1 mark — names at least one specific biotechnology with sufficient detail (e.g. Bt cotton in India; He Jiankui / germ-line CRISPR; AquAdvantage salmon; CAR-T or somatic gene therapy). 1 mark — explicitly distinguishes capability from uptake. 1 mark — invokes economic and/or regulatory context (cost, patents, bans, ownership) with a worked example. 1 mark — invokes social and/or cultural context (public acceptance, trust, values) with a worked example. 1 mark — treats Indigenous and community decision-making as a legitimate part of decision-making rather than as an obstacle. 1 mark — reaches an explicit evaluative judgement that rejects "inevitability" and frames the future as "biologically possible but socially mediated" (or equivalent).